Medytox Inc. - 14 Sep 2022 Form 4 Insider Report for Evolus, Inc. (EOLS)

Role
10%+ Owner
Signature
/s/ Minjung Choi, Senior Manager, on behalf of Medytox Inc.
Issuer symbol
EOLS
Transactions as of
14 Sep 2022
Net transactions value
-$997,778
Form type
4
Filing time
16 Sep 2022, 16:10:31 UTC
Previous filing
12 Sep 2022
Next filing
06 Oct 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction EOLS Common Stock, $0.00001 par value per share Sale $749,674 -73,000 -0.99% $10.27 7,328,652 14 Sep 2022 Direct F1
transaction EOLS Common Stock, $0.00001 par value per share Sale $248,105 -24,000 -0.33% $10.34 7,304,652 15 Sep 2022 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.10 to $10.54, inclusive. The reporting person undertakes to provide to Evolus, Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnotes (1) and (2) to this Form 4.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.17 to $10.43, inclusive.